US Patent 11761000 Compositions and their uses directed to huntingtin
Patent 11761000 was granted and assigned to Ionis Pharmaceuticals, Inc. on September, 2023 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11761000 Compositions and their uses directed to huntingtin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.